Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07197957 · ClinicalTrials.gov registry record
Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
A clinical trial of Acute Kidney Injury, sponsored by BayCare Health System.
- Recruiting
- Registry status
- 100
- Enrollment target
- 4
- Study locations
NCT07197957 is a study of Acute Kidney Injury that is actively recruiting participants, run by BayCare Health System. The registered enrollment target is 100 participants, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT07197957, a study of Acute Kidney Injury, is actively recruiting participants, sponsored by BayCare Health System.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Conditions Studied
Study Locations (4)
Florida
- Morton Plant Hospital - Clearwater
- Morton Plant North Bay Hospital - New Port Richey
- Mease Countryside Hospital - Safety Harbor
- St. Anthony's Hospital - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2027-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07197957
The ClinicalTrials.gov registry entry for NCT07197957 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (96% lower). The listed sponsor is BayCare Health System, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 0 interventions.
NCT07197957 reports 4 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07197957 about?
NCT07197957 is a clinical study titled "Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury". To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
What is the current status of trial NCT07197957?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-03-11. Estimated completion is 2027-02-28.
What conditions does trial NCT07197957 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
Who is sponsoring clinical trial NCT07197957?
This trial is sponsored by BayCare Health System, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07197957 being conducted?
This trial has 4 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.